Norelgestromin/ethinylestradiol: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tag: Reverted |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 20:14, 17 March 2025
Norelgestromin/ethinylestradiol is a combination of two hormones, norelgestromin and ethinylestradiol, used in hormonal contraception. It is marketed under various brand names including Ortho Evra and Xulane.
Etymology
The name "norelgestromin" is derived from "norethindrone", a synthetic progestin, and "gestodene", a third-generation progestin. "Ethinylestradiol" is derived from "estradiol", a naturally occurring estrogen, and "ethinyl", indicating the addition of an ethinyl group.
Pharmacology
Norelgestromin/ethinylestradiol is a transdermal patch that releases the hormones norelgestromin and ethinylestradiol into the bloodstream. Norelgestromin is a progestin, or synthetic progesterone, which works by preventing ovulation and thickening cervical mucus to prevent sperm from reaching the egg. Ethinylestradiol is a synthetic estrogen that works in conjunction with the progestin to prevent ovulation.
Uses
Norelgestromin/ethinylestradiol is used as a method of birth control, to prevent pregnancy. It is also used to treat menstrual disorders, acne, and symptoms of premenstrual syndrome.
Side Effects
Common side effects of norelgestromin/ethinylestradiol include nausea, vomiting, headache, stomach cramping/bloating, breast tenderness, and weight change. Serious side effects include blood clots, stroke, and heart attacks.
See Also
References
<references />


